Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Cabot Corporation (CBT) vs Sensient Technologies Corporation (SXT)

Cabot Corporation and Sensient Technologies Corporation are both Specialty Chemicals companies. Sensient Technologies Corporation is the larger, with a market value of $5.5B against $4.1B — 1.3× the size. Cabot Corporation trades at the lower P/E: 22.1× against 34.7×. Sensient Technologies Corporation grew revenue faster over the last twelve months: 8.12% against −4.74%. Sensient Technologies Corporation has the higher net margin (9.27% vs 5.28%) and the lower return on invested capital (7.51% vs 11.2%). Both pay a dividend; Sensient Technologies Corporation yields more (2.61% vs 2.07%). Across the 23 metrics below, Cabot Corporation leads on 12 and Sensient Technologies Corporation on 11.

Valuation

Metric CBT SXT Specialty Chemicals median
P/E 22.12 34.74 24.83
P/S 1.12 3.21 1.46
P/B 2.34 4.34 1.76
Price to free cash flow 13.19 1,220.99 19.84
EV/EBITDA 7.56 20.58 13.18
EV/Sales 1.40 3.64 1.84
Earnings yield 4.52% 2.88% 2.11%
Free cash flow yield 7.58% 0.08% 2.29%

Profitability

Metric CBT SXT Specialty Chemicals median
Gross margin 22.70% 34.65% 29.23%
Operating margin 13.57% 14.05% 3.63%
Net margin 5.28% 9.27% 2.89%
Free cash flow margin 8.48% 0.26% 3.78%
Return on equity 11.24% 13.07% 3.62%
Return on assets 4.92% 6.90% 0.35%
Return on invested capital 11.18% 7.51% 2.75%

Growth

Metric CBT SXT Specialty Chemicals median
Revenue growth (TTM) (4.74%) 8.12% 4.51%
EPS growth (last fiscal year) (10.42%) 7.48% —
Revenue growth, 5-year CAGR 7.27% 3.89% 6.30%
Net income growth, 5-year CAGR 0.00% 4.20% 0.00%

Health

Metric CBT SXT Specialty Chemicals median
Debt to equity 0.73 0.61 0.54
Current ratio 1.47 4.39 1.94
Net debt to EBITDA 1.13 2.51 2.03

Dividend

Metric CBT SXT Specialty Chemicals median
Dividend yield 2.07% 2.61% 1.69%
Payout ratio 0.29 0.52 0.25

Size

Metric CBT SXT Specialty Chemicals median
Market cap 4.06b 5.46b 2.43b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack